PLSE PULSE BIOSCIENCES, INC.

8-K Current Report

Filed: March 2, 2026

Health Care

Surgical & Medical Instruments & Apparatus

PULSE BIOSCIENCES, INC. (PLSE) 8-K current report filed with SEC EDGAR on March 2, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 5.02: Departure/Election of Directors or Officers

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

• CCO Kevin P. Danahy resigned effective immediately Feb 27, 2026 — abrupt departure with no transition period
• Loss of chief commercial officer is high-impact for a commercial-stage med-tech company dependent on sales execution

+1 more insights

Other PULSE BIOSCIENCES, INC. 8-K Filings

Get deeper insights on PULSE BIOSCIENCES, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.